Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

Thinking about using a CPAP machine to quell sleep apnea? It's not necessarily a good idea for everyone, a new evidence review argues. This common treatment for sleep apnea might increase some folks' ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

What a brutal six months it’s been for Inspire Medical Systems. The stock has dropped 24.3% and now trades at $94.73, ...

The Intersection of Purpose and Progress For most patients, better sleep begins with awareness—and for Ojasvi Razdan, awareness begins with action. Whether through academic research, clinical ...

Engineered for superior comfort, reliability, and usability, Aurora Masks establishes Inogen’s presence in the growing sleep-therapy market and expands Inogen’s addressable market opportunity. The ...

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

Middle-aged adults with comorbid insomnia and sleep apnea faced significantly elevated odds for uncontrolled hypertension vs. adults without these conditions, according to results published in Annals ...

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch ...